US equities
|
MU
$877.55
▲+2.46%
NVDA
$210.96
▼-0.59%
SPCX
$147.49
▲+1.89%
AAPL
$347.73
▼-0.14%
TSLA
$372.22
▼-0.63%
SNDK
$1,238.03
▼-1.82%
META
$642.62
▼-0.96%
AMD
$516.79
▲+1.74%
MU
$877.55
▲+2.46%
NVDA
$210.96
▼-0.59%
SPCX
$147.49
▲+1.89%
AAPL
$347.73
▼-0.14%
TSLA
$372.22
▼-0.63%
SNDK
$1,238.03
▼-1.82%
META
$642.62
▼-0.96%
AMD
$516.79
▲+1.74%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about NASDAQ:GANX
Recent news which mentions NASDAQ:GANX
GANX Stock Earnings: Gain Therapeutics Misses EPS for Q2 2024
August 08, 2024
Tickers
GANX
Tags
NASDAQ:GANX
GANX
Market News
From
InvestorPlace
GANX Stock Earnings: Gain Therapeutics Beats EPS for Q1 2024
May 14, 2024
Tickers
GANX
Tags
NASDAQ:GANX
Market News
GANX
From
InvestorPlace
GANX Stock Earnings: Gain Therapeutics Beats EPS for Q4 2023
March 26, 2024
Tickers
GANX
Tags
GANX
Market News
Today's Market
From
InvestorPlace
Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research
August 29, 2023
Tickers
GANX
Tags
NASDAQ:GANX
From
News Direct